What is Gefitinib: Uses, Dosage, Side Effects and More

Gefitinib is a targeted cancer medication that blocks specific proteins helping certain lung cancers grow. It's part of a group of medicines called tyrosine kinase inhibitors, which work like precise keys that fit into cancer cell locks to stop their growth. This oral medication has become an important treatment option for people with specific types of non-small cell lung cancer, offering hope through its targeted approach.

What is Gefitinib?

Gefitinib is a prescription medication designed to treat advanced non-small cell lung cancer (NSCLC). It belongs to a class of drugs called epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Think of it as a molecular blocker that stops cancer cells from receiving the signals they need to multiply and spread.

This medication comes as oral tablets, making it more convenient than many cancer treatments that require hospital visits for infusion. Gefitinib specifically targets cancer cells with certain genetic mutations, particularly EGFR mutations, which are found in about 10-15% of lung cancers in the United States and up to 50% in some Asian populations.

What is Gefitinib Used For?

Gefitinib is primarily used to treat metastatic non-small cell lung cancer in patients whose tumors have specific EGFR mutations. Your doctor will test your cancer tissue to confirm these mutations are present before prescribing this medication. This testing process is crucial because gefitinib works best when these specific genetic changes are found in your cancer cells.

The medication is typically prescribed when lung cancer has spread to other parts of the body or when surgery isn't an option. It's often used as a first-line treatment for people with EGFR-positive lung cancer, meaning it might be the first cancer medication your doctor recommends. Some doctors may also prescribe it after other treatments haven't worked effectively.

How Does Gefitinib Work?

Gefitinib works by blocking the EGFR protein, which acts like a growth switch inside cancer cells. When this protein is overactive due to genetic mutations, it sends constant "grow and multiply" signals to cancer cells. Gefitinib essentially turns off this switch, helping to slow or stop cancer growth.

This medication is considered a moderately strong cancer treatment with a targeted approach. Unlike traditional chemotherapy that affects both healthy and cancerous cells, gefitinib specifically targets the mutated proteins in cancer cells. This targeted action often means fewer side effects compared to broader chemotherapy treatments, though it's still a potent medication that requires careful monitoring.

The blocking action happens at the cellular level, where gefitinib competes with natural growth factors for binding sites on the EGFR protein. When gefitinib binds to these sites instead, it prevents the cancer cells from receiving growth signals, potentially causing them to stop dividing or even die.

How Should I Take Gefitinib?

Take gefitinib exactly as prescribed by your doctor, usually once daily at the same time each day. You can take it with or without food, but taking it with food may help reduce stomach upset if you experience any. Swallow the tablet whole with a full glass of water, and don't crush, chew, or break it.

If you have trouble swallowing tablets, you can dissolve gefitinib in plain water. Drop the tablet into about half a glass of water, stir until it dissolves completely, and drink the mixture right away. Rinse the glass with more water and drink that too to make sure you get the full dose.

Try to take gefitinib at the same time each day to maintain steady levels in your body. Many people find it helpful to link taking their medication to a daily routine, like having breakfast or brushing their teeth. This consistency helps ensure the medication works most effectively.

How Long Should I Take Gefitinib For?

The duration of gefitinib treatment varies greatly from person to person and depends on how well your cancer responds to the medication. Some people may take it for several months, while others might continue treatment for years. Your doctor will monitor your response through regular scans and blood tests to determine the best treatment length for your situation.

You'll typically continue taking gefitinib as long as it's controlling your cancer and you're tolerating the side effects reasonably well. Your doctor will regularly assess whether the medication is still working effectively through imaging tests like CT scans or PET scans, usually every 2-3 months initially.

If your cancer stops responding to gefitinib or if you develop severe side effects, your doctor will work with you to adjust your treatment plan. This might involve changing the dose, taking treatment breaks, or switching to a different medication. The goal is always to find the right balance between controlling your cancer and maintaining your quality of life.

What Are the Side Effects of Gefitinib?

Like all cancer medications, gefitinib can cause side effects, though many people tolerate it better than traditional chemotherapy. The most common side effects are generally manageable with proper care and monitoring. Understanding what to expect can help you feel more prepared and confident about your treatment.

Here are the most frequently reported side effects that affect many people taking gefitinib:

• Skin problems: Acne-like rash, dry skin, or skin irritation, particularly on the face and upper body
• Digestive issues: Diarrhea, nausea, vomiting, or loss of appetite
• Nail changes: Brittle, cracked, or infected nail beds
• Mouth sores: Small ulcers or irritation inside the mouth
• Fatigue: Feeling more tired than usual or lacking energy
• Eye problems: Dry eyes, irritation, or increased sensitivity to light

Most of these common side effects are mild to moderate and often improve as your body adjusts to the medication. Your healthcare team can provide specific strategies to manage each of these symptoms effectively.

Some people may experience more serious side effects that require immediate medical attention. While these are less common, it's important to know what to watch for:

• Severe breathing problems: New or worsening shortness of breath, cough, or chest pain
• Liver problems: Yellowing of skin or eyes, dark urine, or severe stomach pain
• Severe skin reactions: Widespread rash, blistering, or peeling skin
• Heart problems: Irregular heartbeat, chest pain, or swelling in legs or feet
• Severe diarrhea: More than 6 loose stools per day or signs of dehydration

If you experience any of these serious side effects, contact your doctor immediately or seek emergency medical care. These symptoms, while uncommon, need prompt attention to ensure your safety and well-being.

There are also some rare but potentially serious side effects that occur in a small percentage of people. These include severe lung inflammation (interstitial lung disease), significant liver damage, or severe eye problems that could affect vision. Your doctor will monitor you regularly through blood tests and check-ups to catch any of these issues early.

Who Should Not Take Gefitinib?

Gefitinib isn't suitable for everyone, and certain medical conditions or circumstances may make it unsafe for you to take this medication. Your doctor will carefully review your medical history and current health status before prescribing gefitinib. This thorough evaluation helps ensure the medication is both safe and appropriate for your specific situation.

You should not take gefitinib if you have a known allergy to the medication or any of its ingredients. Signs of an allergic reaction might include severe rash, difficulty breathing, or swelling of your face, lips, tongue, or throat. If you've had allergic reactions to similar medications in the past, make sure to tell your doctor.

Certain medical conditions require special consideration or may make gefitinib unsuitable for you. These conditions need careful evaluation by your healthcare team:

• Severe liver disease: Your liver processes gefitinib, so significant liver problems could be dangerous
• Severe kidney disease: Though less common, kidney problems might affect how your body handles the medication
• Active lung infections: These could be confused with or worsened by potential lung side effects
• Severe heart problems: Gefitinib can occasionally affect heart rhythm or function
• Active eye infections: The medication can cause eye problems, which might be complicated by existing infections

Pregnancy and breastfeeding require special attention when considering gefitinib. This medication can harm developing babies, so if you're pregnant or planning to become pregnant, discuss this thoroughly with your doctor. Both men and women taking gefitinib should use effective birth control during treatment and for several months after stopping the medication.

If you're breastfeeding, you'll likely need to stop before starting gefitinib, as the medication can pass into breast milk and potentially harm your baby. Your doctor can help you weigh the risks and benefits and discuss timing if you're planning to breastfeed in the future.

Gefitinib Brand Names

Gefitinib is most commonly available under the brand name Iressa. This is the original brand name used when the medication was first approved and remains the most widely recognized name for gefitinib worldwide. When your doctor prescribes gefitinib, you'll likely see either "gefitinib" or "Iressa" on your prescription bottle.

In some countries, gefitinib may be available under different brand names or as generic versions. If you're traveling or getting prescriptions filled in different locations, it's helpful to know both the generic name (gefitinib) and the brand name (Iressa) to avoid confusion. Always verify with your pharmacist that you're receiving the correct medication.

Gefitinib Alternatives

Several other medications work similarly to gefitinib for treating EGFR-positive lung cancer. These alternatives might be considered if gefitinib isn't working effectively, if you develop resistance to it, or if you experience intolerable side effects. Your doctor will help determine the best alternative based on your specific cancer characteristics and treatment history.

The most common alternatives include other EGFR inhibitors like erlotinib (Tarceva) and afatinib (Gilotrif). These medications work through similar mechanisms but may have different side effect profiles or effectiveness patterns. Some people who don't respond well to gefitinib might have better success with these alternatives.

For people whose cancer develops resistance to first-generation EGFR inhibitors like gefitinib, newer medications like osimertinib (Tagrisso) might be recommended. This third-generation EGFR inhibitor can often overcome certain types of resistance that develop with gefitinib treatment.

Other treatment options might include traditional chemotherapy, immunotherapy, or combination treatments, depending on your cancer's specific characteristics and your overall health. Your oncologist will work with you to create a comprehensive treatment plan that considers all available options.

Is Gefitinib Better Than Erlotinib?

Both gefitinib and erlotinib are effective EGFR inhibitors, and research shows they have similar effectiveness for treating EGFR-positive lung cancer. The choice between them often comes down to individual factors like side effect tolerance, dosing preferences, and specific cancer characteristics rather than one being definitively "better" than the other.

Some studies suggest slight differences in their side effect profiles. Gefitinib may cause less severe diarrhea and skin problems in some people, while erlotinib might be associated with different patterns of side effects. However, these differences are generally small, and individual responses can vary significantly.

The decision between gefitinib and erlotinib typically depends on your specific situation, including your cancer's genetic profile, your overall health, other medications you're taking, and your personal preferences. Your oncologist will consider all these factors when recommending the most appropriate medication for you.

Both medications have proven track records in treating EGFR-positive lung cancer, and both can significantly improve outcomes for people with this type of cancer. The "better" choice is really the one that works best for your unique situation and that you can tolerate well over time.